Literature DB >> 22437868

Immunotherapy: Combinations that work.

Sarah Seton-Rogers.   

Abstract

Year:  2012        PMID： 22437868     DOI： 10.1038/nrc3250

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  2 in total

Review 1.  Combining immunotherapy and targeted therapies in cancer treatment.

Authors:  Matthew Vanneman; Glenn Dranoff
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

2.  Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.

Authors:  Holbrook E Kohrt; Roch Houot; Kipp Weiskopf; Matthew J Goldstein; Ferenc Scheeren; Debra Czerwinski; A Dimitrios Colevas; Wen-Kai Weng; Michael F Clarke; Robert W Carlson; Frank E Stockdale; Joseph A Mollick; Lieping Chen; Ronald Levy
Journal:  J Clin Invest       Date:  2012-02-13       Impact factor: 14.808
  2 in total
  2 in total

Review 1.  Oncolytic viruses in the treatment of cancer: a review of current strategies.

Authors:  Md Zeyaullah; Mohan Patro; Irfan Ahmad; Kawthar Ibraheem; P Sultan; M Nehal; Arif Ali
Journal:  Pathol Oncol Res       Date:  2012-06-20       Impact factor: 2.874

2.  Stimulation through CD40 and TLR-4 Is an Effective Host Directed Therapy against Mycobacterium tuberculosis.

Authors:  Nargis Khan; Susanta Pahari; Aurobind Vidyarthi; Mohammad Aqdas; Javed N Agrewala
Journal:  Front Immunol       Date:  2016-09-27       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.